Aurinia Pharmaceuticals Inc. - AUPH
Director
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
6
$23.54 M
2,800,000
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
03/04/2025
|
03/04/2025 |
Buy
|
748,038 @ $7.96
|
$5,953,304 | 10,029,500 (8.06%) | Indirect - By LP |
|
03/03/2025
|
03/04/2025 |
Buy
|
452,682 @ $8.01
|
$3,625,474 | 9,281,462 (5.13%) | Indirect - By LP |
|
02/28/2025
|
03/04/2025 |
Buy
|
399,280 @ $7.85
|
$3,134,348 | 8,828,780 (4.74%) | Indirect - By LP |
|
12/09/2024
|
12/09/2024 |
Buy
|
500,000 @ $9.09
|
$4,545,000 | 8,429,500 (6.31%) | Indirect - By LP |
|
12/06/2024
|
12/09/2024 |
Buy
|
400,000 @ $9.01
|
$3,604,000 | 7,929,500 (5.31%) | Indirect - By LP |
|
12/05/2024
|
12/09/2024 |
Buy
|
300,000 @ $8.91
|
$2,673,000 | 7,529,500 (4.15%) | Indirect - By LP |
Singular Genomics Systems, Inc. - OMIC
10% owner
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
3
$1.81 M
122,416
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
09/18/2024
|
09/18/2024 |
Buy
|
32,000 @ $17.21
|
$550,720 | 372,000 (9.41%) | Indirect - By LP |
|
09/17/2024
|
09/18/2024 |
Buy
|
40,000 @ $15.33
|
$613,200 | 340,000 (13.33%) | Indirect - By LP |
|
09/16/2024
|
09/18/2024 |
Buy
|
50,416 @ $12.74
|
$642,300 | 300,000 (20.20%) | Indirect - By LP |